Caxton Associates (New York)’s Nurix Therapeutics NRIX Stock Holding History

Caxton Associates (New York)’s Portfolio NRIX Stock Details NRIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell
2024 Q2	$642K	Buy
2024 Q1	$225K	Buy